Black Race Identified as Top Asthma Inflammation Predictor

New research links Black race and ethnicity to higher rates of specific T-helper 2 inflammation in children with severe asthma.

Updated on Oct. 30, 2026 in Asthma

Isometric editorial illustration of a glass laboratory beaker and a single dropper on a sterile surface, representing medical research. — New research identifies Black race and ethnicity as a primary predictor of T2HIGH inflammation in children with treatment-refractory asthma. AI Illustration. Upload story photo >

Live Poll

Should medical researchers prioritize investigating biological factors over social factors to reduce health disparities?

A study of 451 children with treatment-refractory asthma found that Black race and ethnicity is the primary predictor of T2HIGH inflammation. This specific inflammatory phenotype is characterized by higher levels of blood markers associated with asthma severity.

Why it matters

Understanding the drivers of specific asthma phenotypes is crucial for improving clinical outcomes in children. Identifying these biological predictors helps researchers better distinguish between T2HIGH and T2LOW inflammatory groups.

The study observed that the percentage of children with T2HIGH blood markers doubled from 35% at age 2 to 70% by ages 9 and 14. Researchers utilized multivariable logistic regression and neural network models to analyze the data from 451 pediatric patients.

The players

UVA Health Children's

This medical institution served as the base for the researchers who conducted the study on severe, treatment-refractory asthma.

The details

Researchers defined the T2HIGH group based on the presence of eosinophilia or specific IgE to an allergen, identifying these children as distinct from the T2LOW cohort of 249 patients. By applying advanced statistical models, the study highlights how social and environmental variables intersect with biological markers to influence disease presentation.

The study results were officially published in October 2026.

Health Landscape

This study advances the clinical understanding of the T2HIGH inflammation phenotype within the pediatric asthma population. By linking race and ethnicity to these specific inflammatory profiles, the research provides a new framework for evaluating treatment-refractory asthma cases.

Parents of children with severe, treatment-refractory asthma may discuss these inflammatory markers with their pediatric specialists to better understand their child's specific asthma profile. This research emphasizes the importance of personalized management plans that account for the diverse factors contributing to severe asthma.

The takeaway

Asthma severity in children is heavily influenced by specific biological inflammatory markers that fluctuate significantly during development. Clinicians and families can use these insights to tailor diagnostic and treatment approaches for children struggling with severe symptoms.